Danirixin (GSK1325756)
产品编号: DC9689
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Danirixin 是选择性，可逆的 CXCR2 拮抗剂。抑制 CXCL8的 IC50 值为 12.5 nM。
| Cas No.: |
954126-98-8 |
| 名称: |
|
| 别名: |
Danirixin,GSK 1325756,GSK1325756,GSK-1325756 |
| SMILES: |
CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)[C@H]3CCCNC3)O |
| 分子式: |
C19H21ClFN3O4S |
| 分子量: |
441.9 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
Danirixin is a selective and reversible C-X-C Chemokine Receptor 2 (CXCR2) antagonist that inhibits neutrophil transmigration and activation to areas of inflammation. |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
